In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Pletal, Cilostazol Drug Master File in Korea (Pletal, Cilostazol KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Pletal, Cilostazol. The MFDS reviews the Pletal, Cilostazol KDMF as part of the drug registration process and uses the information provided in the Pletal, Cilostazol KDMF to evaluate the safety and efficacy of the drug.
After submitting a Pletal, Cilostazol KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Pletal, Cilostazol API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Pletal, Cilostazol suppliers with KDMF on PharmaCompass.